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ABSTRACT 
 
AIMS : The aim of the study was to evaluate the the prevalence of thyroid 
dysfunction and  the incidence of autoimmune thyroditis in  rheumatoid arthritis 
METHODS : The study was a  cross sectional observational study involving 50 
rheumatoid arthritis  patients (8 male and 32 female) .The conditions which can 
alter thyroid profile were excluded  from the study population at the time of 
selection . 40 age and sex matched  healthy subjects were taken as controls . 
Thyroid function test were done in all  patients and controls. In patients who were 
found to have thyroid dysfunction TPO  antibodies were done. 
 RESULTS :  Prevalence of thyroid dysfunction is 14% in patients with 
rheumatoid arthritis. Prevalence of thyroid dysfunction in control population was 
5%. Among patients who had thyroid dysfunction there was no statistically 
significant difference in gender. Abnormal thyroid function is mainly in the form 
of both overt and  subclinical hypothyroidism. Prevalence of autoimmune 
hypothyroidism is 22% in our case population. 
 
CONCLUSION :  In summary, our study confirms that the prevalence of thyroid 
dysfunction  in rheumatoid arthritis is high and is associated with thyroid 
autoimmunity and suggest that all rheumatoid arthritis patients should undergo 
thyroid function testing and those with elevated TSH should go for autoimmune 
screening with TPO. 
INTRODUCTION 
 
              Rheumatoid arthritis (RA) is the most common 
inflammatory arthritis affecting about 0.5-1% of general population  
(1).RA is a systemic autoimmune disorder characterised by 
symmetrical, inflammatory, deforming polyarthritis affecting small 
and large peripheral joints with associated systemic disturbance 
such as vasculitis and nodules.  Being an autoimmune disease it can 
be associated with other autoantibody mediated diseases like 
autoimmune thyroididtis (1). The prevalence of thyroid dysfunction 
in rheumatoid arthritis is 10-15% which is high in previous 
studies(2)(3). Autoimmune thyroiditis, specifically Hashimoto's 
thyroiditis, is more prevalent in persons with autoimmune disorders  
including rheumatoid arthritis.  
 
                 Boelaert et al  (4)   investigated the prevalences of and 
relative risks for coexisting autoimmune diseases in patients with 
Graves disease (2791 patients) or Hashimoto thyroiditis (495 
patients). The authors found coexisting disorders in 9.7% of 
patients with Graves disease and in 14.3% of those with Hashimoto 
thyroiditis, with rheumatoid arthritis being the most common of 
these (prevalence = 3.15% and 4.24% in Graves disease and 
Hashimoto thyroiditis, respectively 
. 
             The term autoimmune hypothyroidism identifies situations 
with insufficient thyroid function caused by an autoimmune thyroid 
diseases due to autoimmune destruction of the thyroid gland. In its 
initial stage, chronic autoimmune thyroiditis is characterized by the 
presence of hallmarks of thyroid autoimmunity and normal thyroid 
function. As a consequence of the autoimmune attack to the gland, 
hypothyroidism may develop, usually slowly and insidiously, 
through a subclinical phase levels and an eventual phase of overt 
insufficiency. 
 
         Etiology and pathogenesis of chronic autoimmune thyroiditis 
and mechanisms leading to the hypothyroid phase remain elusive. 
However, some predisposing genetic factors and some triggering 
environmental factors have been identified. The role of antigen-
presenting cells, of T and B-cell response, and of effector 
mechanisms in the immuno pathogenesis of chronic autoimmune 
hypothyroidism has been extensively  investigated. Circulating 
thyroid autoantibodies are the  hallmarks of AITD and thyroid 
peroxidase antibodies is more sensitive than other antibodies in 
identifying thyroid autoimmunity.(5) 
                
              Hypothyroidism is associated with fatigue, anemia, 
arthritis, and myalgia, and also induces destructive arthropathy, 
mainly of the proximal interphalangeal joints which would 
normally be attributed to the inflammatory state of a patient with 
RA. Since autoimmune thryoiditis in rheumatoid arthritis is usually 
asymptomatic, any patient who is not responding to conventional 
treatment of RA or having high levels of TSH should be evaluated  
for autoimmune thryroiditis.  There are studies evidence that RA 
patient having autoimmune thyroiditis  improved symptomatically 
with thyroid supplementation. (6) 
 
 
REVIEW OF LITERATURE 
 
      The thyroid gland produces two related hormones, thyroxine 
(T4) and triiodothyronine (T3).Autoimmune disorders of the thyroid 
gland can stimulate overproduction of thyroid hormones 
(thyrotoxicosis) or cause glandular destruction and hormone  
deficiency (hypothyroidism). 
 Prevalence and clinical relevance 
 In the NHANES III study it was shown that 4.6% of the US 
population had hypothyroidism (0.3% clinical and 4.3% 
subclinical) and 1.3% had hyperthyroidism (0.5% clinical and 0.7% 
subclinical) (7) 
Thyroid Hormone Synthesis 
   Thyroid hormones are derived from Tg, a large iodinated 
glycoprotein. After secretion into the thyroid follicle, Tg is 
iodinated on tyrosine residues that are subsequently coupled via an 
ether linkage. Reuptake of Tg into the thyroid follicular cell allows 
proteolysis and the release of newly synthesized T4 and T3. (8) 
 
 Iodine Metabolism and Transport 
     Iodide uptake is a critical first step in thyroid hormone 
synthesis. Ingested iodine is bound to serum proteins, particularly 
albumin.       The thyroid gland extracts iodine from the circulation 
in a highly efficient manner. Iodide uptake is mediated by NIS, 
which is expressed at the basolateral membrane of thyroid follicular 
cells. Low iodine levels increase the amount of NIS and stimulate 
uptake, whereas high iodine levels suppress NIS expression and 
uptake (8) 
Organification, Coupling, Storage, Release 
After iodide enters the thyroid, it is trapped and transported to 
the apical membrane of thyroid follicular cells, where it is oxidized 
in an organification reaction that involves TPO and hydrogen 
peroxide. The reactive iodine atom is added to selected tyrosyl 
residues within Tg. The iodotyrosines in Tg are then coupled via an 
ether linkage in a reaction that is also catalyzed by TPO. Either T4 
or T3 can be produced by this reaction, depending on the number of 
iodine atoms present in the iodotyrosines. After coupling, Tg is 
taken back into the thyroid cell, where it is processed in lysosomes 
to release T4 and T3. Uncoupled mono- and diiodotyrosines (MIT, 
DIT) are deiodinated by the enzyme dehalogenase, thereby 
recycling any iodide that is not converted into thyroid hormones. 
(8) 
Thyroid Hormone Transport and Metabolism (8)  
Serum Binding Proteins 
T4 is secreted from the thyroid gland in about twentyfold 
excess over T3. Both hormones are bound to plasma proteins, 
including thyroxine-binding globulin (TBG), transthyretin (TTR, 
formerly known as thyroxine-binding prealbumin, or TBPA), and 
albumin. The plasma-binding proteins increase the pool of 
circulating hormone, delay hormone clearance, and may modulate 
hormone delivery to selected tissue sites. The concentration of 
TBG is relatively low (1–2 mg/dL), but because of its high affinity 
for thyroid hormones (T4 > T3), it carries about 80% of the bound 
hormones. Albumin has relatively low affinity for thyroid 
hormones but has a high plasma concentration (3.5 g/dL), and it 
binds up to 10% of T4 and 30% of T3. TTR carries about 10% of T4 
but little T3. 
  Deiodinases 
T4 may be thought of as a precursor for the more potent T3. 
T4 is converted to T3 by the deiodinase enzymes.  
Regulation of thyroid hormone synthesis. (8) 
Thyroid hormones T4 and T3 feed back to inhibit 
hypothalamic production of thyrotropin-releasing hormone (TRH) 
and pituitary production of thyroid-stimulating hormone (TSH).The 
thyroid stimulating hormone (TSH) controls the secretion of T3 and 
T4, plays a pivotal role in control of the thyroid axis and serves as 
the most useful physiologic marker of thyroid hormone action. It is 
secreted in a pulsatile manner with peak secretion at night. Its 
secretion is stimulated by thyrotropin releasing hormone(TRH). 
Both TRH and TSH release are under negative feedback of free  T3 
and T4. 
 
 T3 is bound with 10–15 times greater affinity and ten times 
greater efficacy than T4, which explains its increased hormonal 
potency. Though T4 is produced in excess of T3, receptors are 
occupied mainly by T3.T4 is quantitatively secreted at much higher 
levels, it should be regarded as a pro-hormone that requires 
deiodination and conversion to T3 to become biologically active (8) 
Autoimmune thyroid disease (AITD) : 
     The term "autoimmune thyroid disease" is used to describe all 
autoimmune thyroid conditions, including Graves' disease, 
Hashimoto's thyroiditis, and various other disorders (eg, postpartum 
thyroiditis, most cases of silent thyroiditis). The most common 
presentation is the presence of  positive antithyroid antibodies in a 
euthyroid patient. Hypothyroidism with or without goiter is more 
common than hyperthyroidism. (8) 
         Rheumatic complaints start simultaneously with the first 
symptoms of hypothyroidism and joint pain and swelling usually 
disappear with thyroxine substitution. A study by Gerster Jean 
CHence (6), as thyroxine replacement may reverse the rheumatic 
complaints, thyroid function should be performed as part of the 
biochemical profile in patients with RA not responding to 
antirheumatic treatment. Hypothyroidism should be considered in 
the differential diagnosis of destructive arthropathy ( 11). 
 
 
 
 
 
 
  
PATHOPHYSIOLOGY OF AUTOIMMUNE THYROIDITIS (25) 
 
 
 
 
 
      During Hashimoto's thyroiditis, self-reactive CD4
+
 T 
lymphocytes recruit B cells and CD8
+
 T cells into the thyroid. 
Disease progression leads to the death of thyroid cells and 
hypothyroidism. Both  autoantibodies and thyroid-specific 
cytotoxic T lymphocytes (CTLs) have been proposed to be 
responsible for autoimmune thyrocyte depletion.  
        In Graves' disease, activated CD4
+
 T cells induce B cells to 
secrete thyroid-stimulating immunoglobulin (TSI) against the 
thyroid-stimulating hormone receptor (TSHR), resulting in 
unrestrained thyroid hormone production and hyperthyroidism 
Prevalence 
                  The mean annual incidence rate of autoimmune 
hypothyroidism is up to 4 per 1000 women and 1 per 1000 men. 
The mean age at diagnosis is 60 years, and the prevalence of overt 
hypothyroidism increases with age. Subclinical hypothyroidism is 
found in 6–8% of women (10% over the age of 60) and 3% of men. 
The annual risk of developing clinical hypothyroidism is about 4% 
when subclinical hypothyroidism is associated with positive TPO 
antibodies.(8) 
                 The prevalence of thyroid antibody positivity in the 
general population is 15% to 25% in women and 5% to 10% in 
men. Graves' disease is less prevalent than Hashimoto's thyroiditis. 
(9) 
                The prevalence of thyroid dysfunction and autoimmunity 
in rheumatoid arthritis according to previous studies were   10-20% 
(13, 14, 2, 3 ) and 15-30% respectively. 
              Subclinical hypothyroidism is defined as mild elevation of 
serum thyrotropin (TSH) levels and normal circulating thyroid 
hormone levels. Antithyroid antibodies are positive in 90% of 
affected patients.( 10) 
                   In the Whickham study (15) , in an English town, 8% 
of women 35 years of age and older had subclinical 
hypothyroidism. In that study, old age, female sex, and antithyroid 
antibody positivity were associated with higher risk of progression 
to overt hypothyroidism, and 40% of patients with subclinical 
disease developed clinical hypothyroidism after 20 years. The 
annual rate of progression to overt hypothyroidism was 2.1% in 
women with positive antithyroid antibody (antithyroperoxidase 
antibody or antithyroglobulin antibody) and normal serum TSH, 
2.6% in women with mildly elevated TSH and negative antithyroid 
antibody, and 5% in women with both elevated serum TSH and 
positive thyroid antibody.  (9) 
                 The most common presentation is the presence of 
positive antithyroid antibodies in a euthyroid patient. In such 
patients, a palpable thyroid abnormality may or may not be present. 
Clinical classification of autoimmune thyroid disease(10) 
1. Clinical hypothyroidism with goiter or atrophic thyroid gland 
2. Graves' disease (hyperthyroidism with or without 
extrathyroidal manifestations. 
3. Hashimoto's thyroiditis with positive antithyroid antibodies 
with or without palpable thyroid abnormality 
4. Subclinical hypothyroidism with or without goiter 
5. Transient thyroiditis 
6. Postpartum thyroiditis (transient hyperthyroidism followed 
by transient hypothyroidism. 
7. Silent thyroiditis (transient hyperthyroidism followed by 
euthyroidism) 
Tests to Determine the Etiology of Thyroid Dysfunction 
                   Autoimmune thyroid disease is detected most easily by 
measuring circulating antibodies against TPO and Tg. As 
antibodies to Tg alone are uncommon, it is reasonable to measure 
only TPO antibodies. About 5–15% of euthyroid women and up to 
2% of euthyroid men have thyroid antibodies; such individuals are 
at increased risk of developing thyroid dysfunction. Almost all 
patients with autoimmune hypothyroidism, and up to 80% of those 
with Graves' disease, have TPO antibodies, usually at high levels 
(8) 
                   Thyroid peroxidase antibodies is more sensitive than 
other antibodies in identifying thyroid autoimmunity, which is 
present in 90% of those with autoimmune thyroiditis. So screening 
for TPOA helps in finding out those with AITD (10) 
 
 
 
 
 
Measurement of Thyroid Hormones                
               TSH is the most reliable and sensitive screening test for 
thyroid dysfunction as autoantibodies may persist for many years 
without thyroid dysfunction and allows both hypothyroidism and 
hyperthyroidism to be diagnosed with certainty. TSH levels change 
dynamically in response to alterations of T4 and T3, a logical 
approach to thyroid testing is to first determine whether TSH is 
suppressed, normal, or elevated However, the presence of thyroid 
autoantibodies increases the risk for thyroid disease and so 
particularly those with positive TPO antibodies should undergo 
screening.(8) 
HYPOTHYROIDISM 
                 Hypothyroidism is a clinical syndrome caused by 
decreased levels of thyroid hormones. It can be primary in which 
there is intrinsic disorder of thyroid gland or it may be secondary in 
which there is pituitary or hypothalamic defect. 
                TSH is the single most important parameter for screening 
hypothyroidism. A normal TSH level rules out primary 
hypothyroidism but not secondary. To diagnose primary 
hypothyroidism TSH level should be above 20 μIU/ml or at least 
above 10μIU/ml if clinical features strongly suggest. In the 
presence of elevated TSH, low T4 especially free T4 is necessary to 
confirm hypothyroidism. Circulatory free T3 is usually reduced. 
But it may be normal in 25% of hypothyroid patients. So T3 
measurements are not reliable indicators of hypothyroidism.(8) 
 
HYPERTHYROIDISM 
        Hyperthyroidism is a clinical syndrome which results from 
excessive circulating levels of free thyroid hormones. 
         Laboratory investigations show TSH levels below normal. 
Free and total thyroid hormone levels are increased. In 2 to 5% of 
patients, only T3 is increased and T4 is normal. This condition is 
called "T3 thyrotoxicosis". Occasionally total and free T4 will be 
increased with normal T3 level. This condition is called "T4 
thyrotoxicosis". (8) 
 
 
 
Rheumatoid Arthritis       
 DEFINITION: 
           Rheumatoid Arthritis is a chronic multi system 
inflammatory disorder disease of unknown cause, characterised by 
symmetrical, inflammatory, deforming  polyarthritis(16)  affecting 
small and large peripheral joints with associated systemic 
disturbance such as vasculitis and nodules. 
           Rheumatoid arthritis (RA) is the most common 
inflammatory arthritis affecting about 0.5-1% of general population  
(1)(16). 
 
EPIDEMIOLOGY: 
Incidence             
                  The most recent US data on the incidence of RA is from 
the Rochester Epidemiology Project (12), a study that has provided 
the majority of population-based descriptive statistics on RA.  In 
1995-2007, 41 per 100,000 people were diagnosed with RA each 
year. Incidence rose with age (e.g., 8.7 per 100,000 people among 
those aged 18-34 compared with 54 per 100,000 among those aged 
≥ 85 years); incidence peaked among people aged  65-74 years (89 
per 100,000) (all estimates age- adjusted to 2000 US population). 
From 1995 to 2007, rates increased by 2.5% each year among 
women but there was a small decrease (0.5%) among men (12).  
 
Prevalence:  
               The prevalence of RA is 0.5–1% of the adult population 
worldwide. RA occurs more commonly in females than in males, 
with a 2–3:1 ratio.(16) The onset is more frequent during the fourth 
and fifth decades of life, with 80 % of all patients developing the 
disease between the ages of 35 and 50. (8)(16) 
 
 DIAGNOSIS 
              The American college of Rheumatology (ACR) has 
developed and revised criteria for the classification of RA based on 
a hospital population of patients with established active disease. 
These criteria distinguish active RA from other forms of 
inflammatory arthritis with a diagnostic sensitivity and specificity 
of about 90%.(8)(17). 
The 1987 Revised Criteria for the Classification of RA 
1.  a. Four of seven criteria are required to classify a patient as having 
rheumatoid arthritis (RA). 
  b. Patients with two or more clinical diagnoses are not excluded. 
2. Criteria
a
  
  a. Morning stiffness: Stiffness in and around the joints lasting 1 h before 
maximal improvement. 
  b. Arthritis of three or more joint areas: At least three joint areas, observed by 
a physician simultaneously, have soft tissue swelling or joint effusions, not just 
bony overgrowth. The 14 possible joint areas involved are right or left 
proximal interphalangeal, metacarpophalangeal, wrist, elbow, knee, ankle, and 
metatarsophalangeal joints. 
  c. Arthritis of hand joints: Arthritis of wrist, metacarpophalangeal joint, or 
proximal interphalangeal joint. 
  d. Symmetric arthritis: Simultaneous involvement of the same joint areas on 
both sides of the body. 
  e. Rheumatoid nodules: Subcutaneous nodules over bony prominences, 
extensor surfaces, or juxtaarticular regions observed by a physician. 
  f. Serum rheumatoid factor: Demonstration of abnormal amounts of serum 
rheumatoid factor by any method for which the result has been positive in less 
than 5% of normal control subjects.
 a
Criteria a–d must be present for at least 6 
weeks. Criteria b–e must be observed by a physician.  Source: From Arnett et 
al.(28) 
 
 
ETIOLOGY: 
The initiating cause of rheumatoid arthritis remains unclear. 
1. Genetic factors:- 
               Genetic studies of the distribution of RA in families and 
in mono & dizygotic twins show that there is a small but definite 
contribution of genetic factors to the disease. 
              In twins studies, there is around 12-15% concordance of 
disease in identical twins and around 2- 5% in non-identical twins 
(1).10% of patients with RA will have an affected first degree 
relatives. Recent studies have shown an association between HLA-
DR, (HLADW4 and HLA-DW14) and seropositive disease. In 
Indians RA is most commonly associated with HLA-DR1.(18) 
2. Environmental factors: 
                It has been suggested that RA might be a manifestation of 
the response to an infectious agent in a genetically susceptible host 
.Organism included EBV , CMV , Parovirus B1931, Rubella virus 
and mycoplasma. 
              Cigarette smoking was associated with increased risk of 
RA.(16) 
Exposure silica dust, organic solvent, mineral oils were associated 
with increased risk of RA. The mechanism by which these produce 
damage is not clear, probably by producing persistent infection of 
articular structures and by acting as super antigens. Of all the 
potential environmental structures, the only one clearly associated 
with the development of RA is cigarette smoking.(1) 
3.Host factors. 
          RA is one of many autoimmune diseases that is predominant 
in women. Autoantibody-producing B cells exposed to estradiol are 
more resistant to apoptosis, suggesting that autoreactive B cell 
clones might escape tolerance. The effect on T lymphocytes is 
more difficult to reconcile with the female preponderance in RA 
because estrogen .Estrogen receptors are expressed on fibroblast-
like synoviocytes (FLS) and, when stimulated, increase production 
of metalloproteinases in the synoviums tend to bias T cell 
differentiation toward the T helper type 2 (Th2) phenotype . 
          Exposure to oral contraceptive pills confers protection and 
postpone the onset of RA.(19-20).Pregnancy often is associated 
with remission of the disease in the last trimester. More than three 
quarters of pregnant patients with RA improve in the first or second 
trimester, but 90% of these experience a flare of disease associated 
with an increase in RF titers in the weeks or months after 
delivery.(1) (21-24) 
 
PATHOLOGY: 
1.Rheumatoid disease process in the joints is characterized by(1) 
a. Synovitis 
b. Inflammatory effusion 
c. Cellular exudates into the joint space  
d. Damage to tendon, ligament and bone in and around 
articulating surfaces of the joint by the proliferating 
inflammatory tissue called pannus 
2. Extra articular features associated with RA consist of two types 
of lesion. 
• First is fibrointimal hyperplasia without inflammatory 
changes leading to vascular occlusion. 
• Second lead to extravascular lymphocyte macrophage 
granuloma lesion of RA. 
3. Extravascular nodule formation in areas subject to pressure is 
characteristic granulomatous lesion of RA. 
PATHOGENESIS 
            The inflammatory synovial membrane produces large 
amount of immunoglobulins mainly as RF. In theory, self-reactive 
T cells might arise in RA from abnormal central (thymic) selection 
due to defects in DNA repair leading to an imbalance of T cell 
death and life, or defects in the cell signaling apparatus lowering 
the threshold for T cell activation. The inflammatory synovium 
contains activated T- lymphocyte,  act as helper factors for B-cell 
proliferation, stimulate fibroblast to produce collagen and stimulate 
macrophage.Activated macrophages produce prostaglandin E2 and 
enzyme such as collagenase, IgG and IgM rheumatoid factors, 
elastase and cathepsin, TNF which may play a part in destruction of 
bone and cartilage. Effusion of synovial fluid into joint space takes 
place during active phases of the disease. Hypertrophy of the 
synovial membrane occurs with the formation of lymphoid follicles 
resembling an immunologically active lymph node.  
                      Inflammatory granulation tissue (Pannus) is formed, 
spreading over and under the articular cartilage which is 
progressively eroded and destroyed. Later, fibrous adhesions may 
form between the layers of pannus across the joint space and 
fibrous or bony ankylosis may occur. Muscles adjacent to inflamed 
joints atrophy and there may be focal infiltration with 
lymphocytes.IL-1 and TNF have potent effects on synovial 
fibroblast and chondrocyte function that involve stimulation of 
prostaglandin and collangenase production as well as modulation of 
synthesis of proteoglycans, collagen and fibronectin. These 
cytokines may contribute to the local demineralization of bone by 
activating osteoclasts 
                 Systemic manifestations of RA can be accounted for by 
release of inflammatory molecules from the synovium. These 
include IL-1, TNF, IL-6, which account for many of the 
manifestations of active RA .(8)  
Evidence suggesting RA as autoimmune disease(1) 
              As a consequence of the persistence of the Rheumatoid 
Arthritis Agent and the consequent chronic stimulation of the 
immune response, a variety of auto antibodies are formed and in 
particular rheumatoid factor. These factors and their ability to form 
immune complexes are thought to be responsible for some of the 
inflammatory lesions especially the extraarticular features, seen 
during the course of the disease. Some of the immune complexes 
formed locally in the joint while others may be formed in the 
circulation and  deposition in the tissues. 
 
 Articular Disease:(1) 
                 The most common symptoms are pain and stiffness. The 
latter frequently exhibit diurnal rhythms, worse on early morning. 
The affected joints worse as the disease advances,  muscle atrophy 
tendon sheath and joint destruction results in limitation of joint 
movement, joint instability, subluxation and deformity. 
                  Characteristic deformity include flexion contracture of 
small joints of hands and feet, the knee, hips and elbow. Axial 
involvement of cervical spine occurs in 8%, atlantoaxial 
subluxation upto 25% of patients. Sub axial subluxation present as 
a series risk of cord compression. 
Laboratory Investigations (8) 
          Anemia of chronic disease is seen in the majority of patients 
with RA, and the degree of anemia is proportional to the activity of 
the disease. Therapy that controls the disease results in 
normalization of the hemoglobin. Thrombocytosis is common, with 
platelet counts returning to normal as the inflammation is 
controlled. White blood cell counts may be elevated, normal, or 
profoundly depressed  as in the case of Felty syndrome 
  Acute phase reactants, erythrocyte sedimentation rate and C-
reactive protein levels, also parallel the activity of the disease, and 
their persistent elevation portends a poor prognosis, both in terms 
of joint destruction and mortality 
 Rheumatoid factor, an autoantibody directed against the 
constant (Fc) region of IgG  is positive in about 50% of cases at 
presentation and an additional 20–35% of cases become positive in 
the first 6 months after diagnosis. Rheumatoid factor has an 
unfortunate name because it is not unique to RA and occurs in 
many other diseases, particularly those characterized by chronic 
stimulation of the immune system. In RA, the presence of 
rheumatoid factor is associated with more severe articular disease, 
and essentially all patients with the extra-articular features are 
seropositive for rheumatoid factor.                      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
AIMS AND OBJECTIVES 
 
1. To study the prevalance of thyroid dysfunction in 
rheumatoid arthritis 
2.  To study the incidence of autoimmune thyroditis in  
rheumatoid arthritis 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
 
Study design: 
Cross sectional observational study to analyse the prevalence 
of thyroid dysfunction  and thyroid autoimmunity in rheumatoid 
arthritis . 
Setting: 
Rheumatology and Medicine OPD,  
Govt Rajaji Hospital, Madurai. 
Approval: 
The study was approved by the ethical committee of Govt 
Rajaji Hospital, Madurai. 
Study population: 
Fifty patients of Rheumatoid arthritis and forty age and sex 
matched healthy controls , between the age of 17 to 60 years were 
selected for the study from Rheumatology clinic and outpatient 
department of Internal Medicine, Government Rajaji  Hospital, 
Madurai between (September 2010 to September 2011) after 
thorough history taking and clinical examination and by exclusion 
criteria. All the RA patients were selected on the basis of 1987 
Revised American Rheumatism Association Criteria for the 
classification of rheumatoid arthritis  
INCLUSION CRITERIA:  
Diagnosed cases of  rheumatoid arthritis according to 1987 
Revised American Rheumatism Association Criteria for 
classification of rheumatoid arthritis. 
EXCLUSION CRITERIA: 
  Patients with rheumatoid arthritis with the following 
conditions were excluded from the study 
1. Nephrotic syndrome 
2. Diabetes mellitus 
3. Thyroid disorders 
4. Liver disorders 
5. Drugs like 
             a. Diuretics 
             b. Oral contraceptives 
  Patients suffering from inflammatory diseases, diabetes 
mellitus, renal disorders, thyroid disorders and diseases known to 
affect the hormonal status were excluded from the study. Patients 
on medications known to alter the hormonal levels, pregnant, 
postpartum and post menopausal patients were excluded from the 
study.  
Consent: 
 Patients were informed about the details of the test 
performed and obtained consent before collecting blood samples. 
Any patient not willing to cooperate after initially signing the 
informed consent was allowed to withdraw from the study 
Method of testing: 
   T3,T4, TSH -- Chemiluminescence. 
Thyroid peroxidase -- Enzyme Linked Immuno Sorbent 
Assay. 
Normal ranges: 
T3 --      77-135 ng/dl  
T4  --5.4-11.7  μg/dl 
TSH –0.34-4.2  μIU/ ml 
TPOA upto 75U/ml 
 
Result interpretations: 
 Any T3 /T4 value above the upper limit of normal along 
with a low TSH < 0.34 mIU/ml is considered as 
hyperthyroidism. 
 Any T3 /T4 value below the lower limit of normal along 
with an elevated TSH > 4.2  μIU/ ml is considered as 
hypothyroidism. 
 TSH > 4.2  μIU/ ml along with normal range T3 , T4 is 
considered as  subclinical hypothyroidism. 
 TSH < 0.34 μIU/ ml along with normal range T3 ,T4 is 
considered as subclinical hyperthyroidism. 
 Thyroid autoimmunity is considered to exist if TPOA level 
is > 75IU/ml and not to exist if it is lesser 
 
Statistical analysis: 
Statistical analysis was carried out for 90 participants (50 RA 
patients, 40 controls) after categorizing each variable. Base line 
data was collected from patients.RF,T3,T4,TSH and TPO in 
patients with thyroid dysfunction were analyzed. The significance 
of difference in mean between two groups were analyzed by 
student t test. Statistical significance was taken when p value < 
0.05. Statistical analysis was carried out using standard formulae. 
Microsoft excel 2007 and SPSS (statistical package for social 
sciences) version 13 software was used for data entry and analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OBSERVATIONS AND RESULTS 
 
TOTAL NUMBER OF PATIENTS  : 50 
FEMALE   :  42 
MALE   :  8 
AGE    :  17-60 YEARS 
MEAN AGE : 41.82 YRS 
TOTAL NO. OF HYPOTHYROID PATIENTS : 7 (14%) 
MALE  :  1 
FEMALE :  6 
SUBCLINICAL HYPOTHYROIDISM  :  3(6%) 
OVERT HYPOTHYROIDISM    :  4(8%) 
TOTAL NO. OF HYPERTHYROID PATIENTS. : NIL 
 TOTAL NO. OF HYPOTHYROID PATIENTS  
WITH TPOA   :    2/7 (22%) 
MALE  :  0 
FEMALE  :  2 
MEAN AGE OF PATIENTS WITH AITD : 45.5  YRS 
 
 TABLE 1 
 THYROID STATUS IN RELATION TO GENDER. 
 
THYROID 
STATUS 
 
TOTAL NO. 
(IN%) 
 
GENDER 
 
Male Female 
EUTHYROID 
 
43 (86%) 7 (16.3%) 36 (83.7%) 
HYPOTHYROID 
 
7 (14%) 1 (14.3%) 6 (85.7%) 
HYPERTHYROID 
 
0 
 
0 0 
 
On comparing the female : male 5.2:1 ratio by chi square 
test , the p value is 1.0 and 0.457.. which is > 0.05 . So, the 
association between gender and hypothyroidism is not significant 
indicating that there is no significant gender difference among 
hypothyroid and euthyroid rheumatoid arthritis  as per this study. 
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THYROID STATUS IN RELATION TO GENDER IN 
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 TABLE:2 
COMPARISON OF T3 VALUES IN  
CASES AND CONTROLS 
 
 CASE CONTROL 
MEAN 99.70 134.8 
STANDARD 
DEVIATION 
22.29 31.37 
P VALUE <0.001  
 
 
On comparing the T3 by chi square test , the p value is 0.001 
which is < 0.05 . So,there is  significant abnormality in T3 levels in 
rheumatoid arthritis.  
 
 
 
 
  
 
. CHART 2  
COMPARISON OF T3 VALUES IN  
CASES AND CONTROLS 
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TABLE :3 
COMPARISON OF T4 VALUES IN  
CASES AND CONTROLS 
 
 CASE CONTROL 
MEAN 6.49 9.2 
STANDARD 
DEVIATION 
4.72 3.03 
P VALUE 0.002  
 
On comparing the T4 by chi square test , the p value is 0.002 
which is < 0.05 . So,there is  significant abnormality in T4 levels in 
rheumatoid arthritis 
 
 
                           
                                           CHART 3:   
COMPARISON OF T4 VALUES IN  
CASES AND CONTROLS 
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 TABLE :4 
COMPARISON OF TSH VALUES IN  
CASES AND CONTROLS 
 CASES CONTROLS 
MEAN 2.75 1.96 
STANDARD 
DEVIATION 
1.96 0.96 
P VALUE 0.04  
 
 
On comparing the TSH  by chi square test , the p value is 0.04 
which is < 0.05 . So,there is  significant abnormality in TSH  levels 
in rheumatoid arthritis 
 
 
 
 
 CHART :4 
COMPARISON OF TSH VALUES IN CASES AND 
CONTROLS 
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Table - 5 
AGE WISE  DISTRIBUTION OF THYROID DYSFUNCTION 
 
AGE TOTA
L NO 
EUTHYROID HYPOTH
Y ROID 
SUBCLINICAL 
HYPOTHY 
ROID 
SUBCLINICAL 
HYPER 
THYROIDISM 
20-29 3 1 2 0 0 
30-39 16 15 0 1 0 
40-49 21 19 2 0 0 
50-50 7 6 0 1 0 
60-69 3 2 0 1 0 
 
In our study thyroid dysfunction in rheumatoid arthritis  is 
common in 20-50 age group. 
 
 
 
 
 
 Chart - 5 
PREVALENCE OF THYROID DYSFUNCTION IN 
RHEUMATOID ARTHRITIS 
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Chart - 6 
PREVALENCE OF AUTOIMMUNE HYPOTHYROIDISM 
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Chart – 7 
Rheumatoid Factor 
 
 
 
18 cases were  RF positive and 32 were RF  negative 
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INTERPRETATION OF RESULTS: 
 
 Among patients with thyroid dysfunction in rheumatoid 
arthritis there is no statistically significant difference in 
gender . 
 Prevalence of thyroid dysfunction in rheumatoid arthritis 
is 14%. 
 Abnormal thyroid function is mainly in the form of both 
overt and  subclinical hypothyroidism. 
 Prevalence of autoimmune Hypothyroidism in rheumatoid 
arthritis  is 22%. 
 
 
 
 
 
  
DISCUSSION 
 
Prevalence of Thyroid dysfunction in rheumatoid arthritis: 
        The reported prevalence of thyroid dysfunction in rheumatoid 
arthritis populations varies widely between studies. But, thyroid 
dysfunction is found to be associated with organ specific antibody. 
           In a  study by Fabiola Atzeni (13)to assess thyroid function 
as well as the prevalence and clinical value of anti-thyroid 
antibodies in patients with rheumatoid arthritis (RA) done in 70 RA 
patients , 9 males and 61 females, mean age 47 years (range 15–77) 
were analyzed. : Twenty-six patients (37%) with RA were positive 
for TPOAb and 16 (23%) for TgAb. In 5 (7.1%) patients TSH level 
was slightly elevated. The increase of TSH levels was associated 
with normal FT4 in 3 cases (4.2%) and with reduced FT4 in 2 cases 
(2.8%). One patient (1.5%) had low TSH serum value along with 
normal FT4.   
        Another study by(14). Caron P, Lassoued S, Dromer C, 
Oksman F, Fournie A to find the  prevalence of thyroid 
abnormalities in patients with rheumatoid arthritis. Prevalence of  
hypothyroidism  and autoimmune thyroiditis and was  19.1% and 
16.2% respectively. 
          In study by (2)Przygodzka M, Filipowicz-Sosnowska  
regarding prevalence of thyroid diseases and antithyroid antibodies 
in women with rheumatoid arthritis done among 100 patients with 
RA thyroid function and antithyroid antibodies were assessed. ATD 
was more prevalent (16%) in patients with RA than in the control 
group (9%). The difference was no statistically significant. 
Antithyroglobulin (anti-TG) and antithyroid peroxidase (anti-TPO) 
antibodies were (12% and 15%, respectively) in patients with RA  
and (9% and 18%, respectively) in the control group . The most 
common thyroid dysfunction observed in both groups was 
subclinical hypothyroidism. 
            A  study by (3) El-Sherif WT  El Gendi SS, Ashmawy MM, 
Ahmed HM Salama MM thyroid disorders and autoantibodies in 
systemic lupus erythematosus and rheumatoid arthritis done among  
20 patients with SLE and  20 with RA were studied. The results 
were compared with  20 healthy age and sex matched controls. This 
study revealed that thyroid disorders in RA, 10% had 
hypothyroidism (subclinical) and 5% had subclinical 
hyperthyroidism. TPOAb was found in 5% of RA patients and 10% 
of controls.  
              A study by Gonçalves, Fabrícia Torres MD et al, (26) 
autoimmune thyroiditis and rheumatoid arthritis :is there really an 
association? done in 189 patients and 117 with nonautoimmune 
rheumatic diseases. Thyroid dysfunction was found in 11, and 
thyroid autoantibodies in 15 RA patients, compared with 18 and 13 
of the control group, respectively. The  conclusion was there is  no 
association  between thyroid disease and RA.  
      On the whole, in agreement with many similar reports, we 
observed a higher prevalence of thyroid dysfunction in our study 
and hypothyroidism was the thyroid dysfunction found ,none of the 
patients had hyperthyroidism. 
Prevalence of Thyroid autoimmunity in ra: 
              In study by(2) Przygodzka M, Filipowicz-Sosnowska A  
regarding prevalence of thyroid diseases and antithyroid antibodies 
in women with rheumatoid arthritis done among 100 patients with 
RA thyroid function and antithyroid antibodies were assessed. ATD 
was more prevalent (16%) in patients with RA than in the control 
group (9%). The difference was no statistically significant. 
Antithyroglobulin (anti-TG) and antithyroid peroxidase (anti-TPO) 
antibodies were present in similar percentage of patients with RA 
(12% and 15%, respectively) and in the control group (9% and 
18%, respectively. 
             (3) El-Sherif WT  El Gendi SS, Ashmawy MM, Ahmed 
HM Salama MM Thyroid disorders and autoantibodies in systemic 
lupus erythematosus and rheumatoid arthritis done among  20 
patients with SLE and  20 with RA were studied. The results were 
compared with  20 healthy age- and sex- matched controls. TPOAb 
was found in  5% of RA patients and  10% of controls, and  
ATGAb 30% of RA patients and 10% of controls. 
          In a  study by(13) Fabiola Atzeni to assess thyroid function 
as well as the prevalence and clinical value of anti-thyroid 
antibodies in patients with rheumatoid arthritis (RA) done in 70 RA 
patients , 9 males and 61 females, mean age 47 years (range 15–77) 
were analyzed. : Twenty-six patients (37%) with RA were positive 
for TPOAb and 16 (23%) for TgAb. In 5 (7.1%) patients TSH level 
was slightly elevated,  this study shows an increased prevalence of 
anti-thyroid antibodies in RA patients with a low prevalence of 
hormonal alterations 
                 On analysing TPO antibodies in those with thyroid 
dysfunction prevalence was 22 % which was also comparable with 
the previous studies.  
 
 
 
 
 
 
 
 
 
  
 
 
 
CONCLUSION 
 
 Prevalence of hypothyroidism  in RA is more than that seen 
among general population. 
 Some patients develop subclinical form of the disease thus 
reducing the possibility of clinical suspicion. 
 There is an association of thyroid autoimmunity and thyroid 
dysfunction in RA. 
 
                  In summary, our study confirms that the prevalence of 
thyroid dysfunction  in rheumatoid arthritis is high and is 
associated with thyroid autoimmunity and suggest that all 
rheumatoid arthritis patients should undergo thyroid function 
testing and those with elevated TSH should go for autoimmune 
screening with TPO. 
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PROFORMA 
STUDY OF THYROID DYSFUNCTION IN RHEUMATOID 
ARTHRITIS 
Name :                       
Age  :    
Sex  : 
Ip no  : 
Address : 
Phone no : 
C/F 
Hyperthyroidism:  
Hyperactivity, irritability 
Heat intolerance 
Palpitation 
Weakness 
Wt loss 
Diarrhoea 
Polyuria 
 
 
 
 
 
 
 
 
Hypothyroidism: 
 Fatigue                               
Wt gain 
dry coarse skin 
Cold intolerance 
Puffy face 
Constipation 
Hoarse voice 
PAST HISTORY  :                                                                      
HTN  / DM     /  TB  /   BA  /ATT    /CAD  / 
CVA      /         RHD/ 
Hypothyroidism 
Hyperthyroidism 
On thyroxine 
Antithyroid  drugs 
PERSONAL HISTORY 
Smoking ,  alcoholism   
GENERAL EXAMINATION 
PR  
BP 
Jaundice 
Pallor/odema/cyanosis 
 
 
 
 
 
Hypothyroidism 
 Thyroid swelling 
Alopecia 
Carpel tunnel syndrome 
Serous cavity effusion 
 Bradycardia 
Pseudomyotonia 
 Peripheral odema 
Hyperthyroidism 
Tachycardia,AF 
Tremor 
Goiter 
INVESTIGATIONS: FOR THYROID DYSFN 
T4 
T3 
TSH 
Anti-TPO 
Investigations for RA 
RA factor 
         
ABBREVIATIONS 
    
T4 - Tetraiodothyronine 
T3 - Triiodothyronine 
TSH - Thyroid stimulating hormone 
Tg - Thyroid globulin 
TPO - Thyroid peroxidase 
AITD- Autoimmune thyroid disease 
RA - Rheumatoid Arthritis 
 
 
 
 
 
                                                                               
 
 
 
 
                               MASTER  CHART-CASES 
S.No name age sex RF T3 T4 TSH TPO 
1 lexmi 40 F y 110.54 10.9 2.7   
2 ravi 40 M y 91.86 6.4 3.3   
3 ibrhim 51 M n 125.37 8.9 2.4   
4 mariama 53 F y 96.8 8.8 5.26 14.4 
5 alagamma 30 f y 123.72 9.2 4.65 16.2 
6 paramesh 27 f y 90.8 1.13 8 124 
7 subalexmi 59 f n 63.68 6.8 5.46 150 
8 velmani 30 f n 116.83 10.3 2.6   
9 muthumar 36 f y 96.97 10.7 0.9   
10 mathai 60 m n 89.59 7.1 2.5   
11 alagu 48 m n 104.6 9.7 2.4   
12 jayamala 30 f n 98.41 18.3 0.84   
13 muthurak 48 f n 131.78 11.5 2.48   
14 adakala 45 f n 144.77 7.6 2.87   
15  muthu.k 48 m n 114.65 10.5 2.8   
16 lexmi 34 f y 65.22 6.4 2.7   
17 nagalexm 44 f n 122.89 11.6 4.15   
18 dhanam 55 f n 56.35 8 2.4   
19 kavitha 35 f n 99.03 9.2 2.3   
20 muthulex 60 f n 98.67 11.1 0.49   
21 muthurak 40 f y 136.22 9.4 1.6   
22 rabith 43 f y 89 9.6 0.66   
23 raja 43 m y 89.49 9.6 2.3   
24 kalavathi 43 f n 87.94 8.3 2.13   
25 thenmozhi 45 f n 109.4 9.4 2.2   
26 pushpa 49 f n 99.32 10.3 2.77   
27 jothimani 44 f y 78.56 8.9 1.95   
28 sivakami 25 f n 92.67 10.6 2.7   
29 panchavar 34 f y 91.32 9.3 4.12   
30 manimala 33 f n 160 1.19 2.5   
31 rajathi 40 f n 33 1.3 7.8 68 
32 kamala 55 f n 78 1.16 2.4   
33 sankar 56 m n 90 1.07 1.6   
34 arumugm 59 m n 80.6 0.81 0.6   
35 santhi 35 f n 87.8 0.99 2.9   
36 kripavathi 39 f n 80 1.03 1.8   
37 kavitha 18 f n 120 0.92 1.7   
38 vasanthy 35 f y 140 1.68 0.76   
39 valarmath 49 f y 130 1.51 2.5   
40 meena 45 f n 120 1.5 0.72   
41 shamala 32 f y 80 1.57 2.7   
42 kanimozhi 33 f y 120 0.98 3.8   
43 sumathy 28 f n 130 1.2 8.9 64 
44 rama 40 f y 50 0.31 6.7 48 
45 veena 38 f n 128 0.97 2.4   
46 lalitha 45 f n 90.2 2.4 3.4   
47 mari 50 f y 74 0.44 4.1   
48 thangam 42 f n 88 8.4 2.4   
49 leelavathi 36 f n 90.6 7.6 1.56   
50 jayamala 30 f n 98.41 18.3 1.4   
S.No. name age  sex T3 T4S TSH 
1 kala 28 f 130 12.62 1.36 
2 Raman 51 m 126 8.6 1.22 
3 ramany 53 f 114 8.8 2.2 
4 kalavathy 30 f 128 12.6 2.4 
5 parvathy 27 f 110 7.6 2.34 
6 kalyani 60 f 90 5.5 0.72 
7 Ramesh 40 m 136 2 2.6 
8 nithya 33 f 75 4.4 1.3 
9 muthulexmi 40 f 128 13.2 0.02 
10 rasiya 32 f 140 9.7 2 
11 meena 49 f 240 12.3 1.8 
12 mariya 45 f 111 11.6 1.6 
13 meenakshi 35 f 128 10 2.2 
14 kavitha 18 f 147 10.2 4.1 
15 suhasini 39 f 128 12.4 2.57 
16 subalexmi 35 f 142 7.1 0.58 
17 Senthil 59 m 155 8.4 5.2 
18 padma 55 f 140 5.4 2.1 
19 revathi 40 f 136 16.3 1.2 
20 sumathy 33 f 168 5.7 2.2 
21 panchu 34 f 178 8.2 2.9 
22 amritha 25 f 136 7.6 2.4 
23 chandra 48 f 87 4.6 1.6 
24 indira 49 f 196 7.1 1.8 
25 umavathy 45 f 135 8.9 2.6 
26 rakku 42 f 160 9.5 0.44 
27 Murugan 43 m 116 5.6 2.6 
28 sormam 43 f 126 10.7 2.1 
29 gandhimathy 40 f 130 13 2.6 
30 yamini 60 f 170 10.8 2.5 
31 deepa 35 f 136 9.2 1.5 
32 muthuraku 55 f 148 10 2.8 
33 ramany 45 f 163 12.1 2.4 
34 radha 34 f 128 10.7 2.2 
35 Selvan 48 m 168 7 2.4 
36 jannet 45 f 98 9.9 0.8 
37 indhumathi 45 f 110 11.5 2.4 
38 sandhya 30 f 122 11 3 
39 Mariappan 48 m 138 11.9 3.3 
40 susheela 33 f 75 4.4 1.3 
 
